AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17909381 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement interventions aimed at medical care providers
Number of subjects: 0
Study 17909381 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of automated records for trial design
Number of subjects: 0
Study 15759538 — intervention group
Group type: EXPERIMENTAL
Intervention: Berg Balance Scale
Number of subjects: 47
Study 15759538 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivermead Mobility Index
Number of subjects: 47
Study 15759538 — intervention group
Group type: EXPERIMENTAL
Intervention: Barthel Activities of Daily Living Index
Number of subjects: 47
Study 11983043 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (0.15 mg/kg in 3 ml saline)
Number of subjects: 20
Study 11983043 — intervention group
Group type: COMPARATOR
Intervention: Saline (3 ml)
Number of subjects: 20
Study 9858980 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine
Number of subjects: 8
Study 9858980 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive cuffs
Number of subjects: 8
Study 9858980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8572653 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionibacterium avidum KP‐40
Number of subjects: 0
Study 8572653 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP‐45
Number of subjects: 0
Study 8572653 — intervention group
Group type: COMPARATOR
Intervention: Control (non Propionibacterium avidum KP‐40 treated)
Number of subjects: 0
Study 2539186 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (150 mg single oral dose)
Number of subjects: 369
Study 2539186 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole (200 mg intravaginal daily for 3 days)
Number of subjects: 369
Study 7027234 — intervention group
Group type: EXPERIMENTAL
Intervention: Special risk factor intervention program directed at the reduction of elevated serum cholesterol, elevated diastolic blood pressure, and cigarette smoking
Number of subjects: 12000
Study 7027234 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 12000
Study 31732552 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (EG) participated in a 3-month exercise program
Number of subjects: 100
Study 31732552 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) received no intervention
Number of subjects: 100
Study 31732552 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 31015099 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 120
Study 31015099 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic-Focused Psychodynamic Psychotherapy (PFPP)
Number of subjects: 120
Study 31015099 — intervention group
Group type: COMPARATOR
Intervention: Both CBT and PFPP
Number of subjects: 120
Study 27927588 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10; 1,200mg)
Number of subjects: 65
Study 27927588 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10; 600mg)
Number of subjects: 65
Study 27927588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 25925701 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000 (Monofer®)
Number of subjects: 351
Study 25925701 — intervention group
Group type: COMPARATOR
Intervention: Iron sucrose (Venofer®)
Number of subjects: 351
Study 23377324 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar radiofrequency system (Pellevé S5 Wrinkle Treatment Generator)
Number of subjects: 31
Study 21834655 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored footwear programme (player education, prescription of footwear, frequent rotation of footwear)
Number of subjects: 59
Study 21834655 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored footwear programme
Number of subjects: 59
Study 19397073 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 135
Study 19397073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 20057896 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (specific dosage and duration not mentioned)
Number of subjects: 0
Study 20057896 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 15688690 — intervention group
Group type: EXPERIMENTAL
Intervention: Dan Zhi Xiao Yao Yin combined with auricular-point-pressing therapy
Number of subjects: 51
Study 15688690 — intervention group
Group type: COMPARATOR
Intervention: Routine western drugs
Number of subjects: 51
Study 12182776 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulated four-contact array (laminectomy)
Number of subjects: 24
Study 12182776 — intervention group
Group type: COMPARATOR
Intervention: Permanent percutaneous electrode
Number of subjects: 24
Study 12182776 — intervention group
Group type: COMPARATOR
Intervention: Temporary percutaneous electrode
Number of subjects: 24
Study 9006703 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at 65 degrees C
Number of subjects: 6
Study 9006703 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at 70 degrees C
Number of subjects: 6
Study 9006703 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at 75 degrees C
Number of subjects: 6
Study 9006703 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at 80 degrees C
Number of subjects: 6
Study 9006703 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at 65 degrees C, 70 degrees C, 75 degrees C, and 80 degrees C
Number of subjects: 6
Study 9006703 — intervention group
Group type: COMPARATOR
Intervention: Temperature at 37 degrees C
Number of subjects: 6
Study 8214995 — intervention group
Group type: EXPERIMENTAL
Intervention: CMVIG
Number of subjects: 141
Study 8214995 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1% albumin)
Number of subjects: 141
Study 3565119 — intervention group
Group type: EXPERIMENTAL
Intervention: Floating environment intervention; duration not specified.
Number of subjects: 0
Study 3565119 — intervention group
Group type: COMPARATOR
Intervention: Control subjects; procedures used on them not specified.
Number of subjects: 0
Study 11600543 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 43
Study 11600543 — intervention group
Group type: EXPERIMENTAL
Intervention: Holding the infant
Number of subjects: 43
Study 11600543 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43
Study 30984980 — intervention group
Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 70
Study 30984980 — intervention group
Group type: COMPARATOR
Intervention: LASIK
Number of subjects: 70
Study 30348137 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention (group-based program delivered by trained peer volunteers over 12 months)
Number of subjects: 0
Study 25946038 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% of V ˙ O 2 m a x training intensity
Number of subjects: 12
Study 25946038 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% of V ˙ O 2 m a x training intensity
Number of subjects: 12
Study 24887611 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-selective attention task (Attend vs Ignore)
Number of subjects: 38
Study 23167405 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus 1-week continuous infusion of 5-FU (1000 mg/d) and heparin (5000 IU/d) infusion initiated from the day of surgery for 7 consecutive days (study group)
Number of subjects: 64
Study 23167405 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (observational group)
Number of subjects: 64
Study 20479295 — intervention group
Group type: EXPERIMENTAL
Intervention: Appearance-focused intervention including a booklet discussing tanning history, UV radiation effects, and healthier alternatives.
Number of subjects: 430
Study 20479295 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 430
Study 18661551 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) just before surgery
Number of subjects: 3
Study 18661551 — intervention group
Group type: COMPARATOR
Intervention: Control group (not being considered for DBS)
Number of subjects: 3
Study 15644155 — intervention group
Group type: EXPERIMENTAL
Intervention: Xincang Decoction
Number of subjects: 60
Study 15644155 — intervention group
Group type: COMPARATOR
Intervention: Ketotifen fumarate
Number of subjects: 60
Study 11823651 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke unit care for large-vessel infarcts
Number of subjects: 267
Study 11823651 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke unit care for lacunar strokes
Number of subjects: 267
Study 11823651 — intervention group
Group type: COMPARATOR
Intervention: Stroke team care for large-vessel infarcts
Number of subjects: 267
Study 11823651 — intervention group
Group type: COMPARATOR
Intervention: Stroke team care for lacunar strokes
Number of subjects: 267
Study 10730517 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium Bb12 supplemented milk-based formula
Number of subjects: 175
Study 10730517 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium Bb12 and Streptococcus thermophilus supplemented milk-based formula
Number of subjects: 175
Study 10730517 — intervention group
Group type: COMPARATOR
Intervention: Milk-based follow-up formula (Control)
Number of subjects: 175
Study 7670454 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% carbohydrate‐electrolyte (CE) drink
Number of subjects: 8
Study 7670454 — intervention group
Group type: COMPARATOR
Intervention: Flavored water placebo (PL)
Number of subjects: 8
Study 1844536 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine
Number of subjects: 0
Study 1844536 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine/Clindamycin
Number of subjects: 0
Study 1844536 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 0
Study 1844536 — intervention group
Group type: COMPARATOR
Intervention: 4-aminoquinolines and sulfadoxine-pyrimethamine
Number of subjects: 0
Study 7283808 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% dipivefrin twice a day plus 0.25% echothiophate iodide twice a day
Number of subjects: 8
Study 7283808 — intervention group
Group type: COMPARATOR
Intervention: 2% epinephrine hydrochloride twice a day plus 0.25% echothiophate iodide twice a day
Number of subjects: 8
Study 31159569 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction Kinesiotaping
Number of subjects: 7
Study 31159569 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesiotaping
Number of subjects: 7
Study 28012168 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent housing subsidies that reduce expenditures for rent to 30% of families' income
Number of subjects: 1857
Study 28012168 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary rapid re‐housing subsidies with some services directed at housing and employment
Number of subjects: 1857
Study 28012168 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional housing in supervised facilities with extensive psychosocial services
Number of subjects: 1857
Study 28012168 — intervention group
Group type: COMPARATOR
Intervention: Usual care families (control group)
Number of subjects: 1857
Study 24755722 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital
Number of subjects: 20
Study 24755722 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 20
Study 23728931 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist diet and exercise advice tailored to individual family circumstances
Number of subjects: 32
Study 23728931 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of children in the decision to attend a clinic
Number of subjects: 32
Study 23728931 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic environment
Number of subjects: 32
Study 22264722 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (V; 160 then 320 mg/day)
Number of subjects: 30
Study 22264722 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (C; 20 then 40 mg/day)
Number of subjects: 30
Study 22264722 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril (L; 40 mg/day)
Number of subjects: 30
Study 19066176 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus methotrexate
Number of subjects: 444
Study 19066176 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg plus placebo
Number of subjects: 444
Study 19066176 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg plus methotrexate
Number of subjects: 444
Study 19066176 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg plus methotrexate
Number of subjects: 444
Study 17878518 — intervention group
Group type: EXPERIMENTAL
Intervention: 70-gene signature (Mammaprint®™) for selecting patients for adjuvant chemotherapy
Number of subjects: 0
Study 17878518 — intervention group
Group type: COMPARATOR
Intervention: Conventional clinicopathological criteria for adjuvant chemotherapy
Number of subjects: 0
Study 16279899 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg-IFN-alpha2b + RBV for 24 weeks
Number of subjects: 180
Study 16279899 — intervention group
Group type: COMPARATOR
Intervention: Peg-IFN-alpha2b + RBV for 48 weeks (Control)
Number of subjects: 180
Study 16279899 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction-dose triple therapy (IDTT) with IFN-alpha2b + RBV + AMD for 24 weeks
Number of subjects: 180
Study 11329797 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial therapy
Number of subjects: 0
Study 9707202 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching intervention for nurses on positioning stroke patients
Number of subjects: 38
Study 9707202 — intervention group
Group type: COMPARATOR
Intervention: Control group (no teaching intervention)
Number of subjects: 38
Study 9071414 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser and adjuvant systemic interferon alpha-2b
Number of subjects: 100
Study 9071414 — intervention group
Group type: COMPARATOR
Intervention: Carbon dioxide laser and placebo
Number of subjects: 100
Study 2448561 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodilution (by venesection and replacement of the same volume of dextran 40 in saline solution)
Number of subjects: 1267
Study 2448561 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 1267
Study 2448561 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodilution
Number of subjects: 1267
Study 31713952 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed working memory training (45-min sessions, 5 days a week over 5-7 weeks)
Number of subjects: 91
Study 31713952 — intervention group
Group type: COMPARATOR
Intervention: Placebo program (45-min sessions, 5 days a week over 5-7 weeks)
Number of subjects: 91
Study 31397263 — intervention group
Group type: EXPERIMENTAL
Intervention: 4AT (n = 392)
Number of subjects: 785
Study 31397263 — intervention group
Group type: COMPARATOR
Intervention: CAM (n = 382)
Number of subjects: 785
Study 31397263 — intervention group
Group type: EXPERIMENTAL
Intervention: 4AT positive scores
Number of subjects: 785
Study 31397263 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial inpatient stay for patients with delirium
Number of subjects: 785
Study 31397263 — intervention group
Group type: EXPERIMENTAL
Intervention: False-positive cases
Number of subjects: 785
Study 31397263 — intervention group
Group type: EXPERIMENTAL
Intervention: False-negative cases
Number of subjects: 785
Study 31397263 — intervention group
Group type: EXPERIMENTAL
Intervention: Missed diagnosis
Number of subjects: 785
Study 28146219 — intervention group
Group type: EXPERIMENTAL
Intervention: ABBM-PRF combination
Number of subjects: 15
Study 28146219 — intervention group
Group type: COMPARATOR
Intervention: ABBM alone (control group)
Number of subjects: 15
Study 26788875 — intervention group
Group type: EXPERIMENTAL
Intervention: Santes® (two suppositories per day for 4 months, first two months simultaneous to RT and BRT)
Number of subjects: 45
Study 26788875 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment during RT)
Number of subjects: 45
Study 26788875 — intervention group
Group type: EXPERIMENTAL
Intervention: Santes® (two suppositories per day for 4 months)
Number of subjects: 45
Study 23167574 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm showers (20 minutes duration, water temperature maintained at 37°C)
Number of subjects: 80
Study 23167574 — intervention group
Group type: COMPARATOR
Intervention: Standard childbirth care (control group)
Number of subjects: 80
Study 23167574 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm showers
Number of subjects: 80
Study 21808190 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral micronized progesterone (100 mg)
Number of subjects: 9
Study 21808190 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.06, 0.12 and 0.25 mg/70 kg)
Number of subjects: 9
Study 21808190 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of progesterone and triazolam
Number of subjects: 9
Study 21808190 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone alone
Number of subjects: 9
Study 21808190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 19537955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 412
Study 16641126 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (5 mg chewable tablets administered once daily in the evening)
Number of subjects: 32
Study 16641126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15613121 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured weekly educational telephone intervention (8 weeks)
Number of subjects: 168
Study 15613121 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 168
Study 11004060 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive warming (maintaining tympanic membrane temperature of 36.5 degrees C)
Number of subjects: 150
Study 11004060 — intervention group
Group type: COMPARATOR
Intervention: Conventional warming (maintaining temperature of 36 degrees C)
Number of subjects: 150
Study 8639197 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine (10 mg)
Number of subjects: 86
Study 8639197 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg)
Number of subjects: 86
Study 8639197 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile saline)
Number of subjects: 86
Study 1317272 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (1.2 mg)
Number of subjects: 12
Study 1317272 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 12
Study 1317272 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 12
Study 6140906 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipecac (30 mL, repeated if vomiting not induced)
Number of subjects: 12
Study 6140906 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (60 g) with magnesium sulfate (MgSO4)
Number of subjects: 12
Study 6140906 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipecac followed by activated charcoal/MgSO4 (given 1 1/2 hours after last vomiting episode)
Number of subjects: 12
Study 6140906 — intervention group
Group type: COMPARATOR
Intervention: Control (aspirin only)
Number of subjects: 12
Study 31793541 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustagard Artro (1 sachet once a day for 6 weeks)
Number of subjects: 60
Study 31793541 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (injectable forms for 3-7 days)
Number of subjects: 60
Study 31793541 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustagard Artro (CP)
Number of subjects: 60
Study 31793541 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 60
Study 28664576 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasodilator stress with dipyridamole
Number of subjects: 18
Study 28664576 — intervention group
Group type: EXPERIMENTAL
Intervention: Modest plantar flexion exercise (20 watts)
Number of subjects: 18
Study 28664576 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical revascularization followed by exercise
Number of subjects: 18
Study 26553615 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/mL histamine
Number of subjects: 24
Study 26553615 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/mL histamine
Number of subjects: 24
Study 26553615 — intervention group
Group type: EXPERIMENTAL
Intervention: All devices tested
Number of subjects: 24
Study 26553615 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-Test PC and UniTest PC
Number of subjects: 24
Study 26553615 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiheaded vs single-head devices
Number of subjects: 24
Study 23639228 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod (800 mg single dose)
Number of subjects: 0
Study 23639228 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited Sampling Strategy (LSS)
Number of subjects: 0
Study 23639228 — intervention group
Group type: EXPERIMENTAL
Intervention: Two formulations of pidotimod
Number of subjects: 0
Study 23639228 — intervention group
Group type: EXPERIMENTAL
Intervention: LSS method for assessing bioequivalence
Number of subjects: 0
Study 20858104 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional RT plus intracavity hyperthermia (T90 42.5°‐43°C for 50 min twice a week for 7 weeks)
Number of subjects: 180
Study 20858104 — intervention group
Group type: COMPARATOR
Intervention: Conventional RT alone
Number of subjects: 180
Study 20858104 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional RT plus intracavity hyperthermia
Number of subjects: 180
Study 19463505 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate turbulence (HRT) using 24-hour Holter monitoring
Number of subjects: 481
Study 17725476 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary pelvic floor muscle contraction in standing
Number of subjects: 65
Study 17725476 — intervention group
Group type: COMPARATOR
Intervention: Voluntary pelvic floor muscle contraction in crook‐lying
Number of subjects: 65
Study 15113612 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dose combination (FDC) tablet of rifampicin, isoniazid, and pyrazinamide
Number of subjects: 22
Study 15113612 — intervention group
Group type: COMPARATOR
Intervention: Standard separate combination of rifampicin, isoniazid, and pyrazinamide
Number of subjects: 22